Top 10 stocks for today – 30th June, 2023

30 Jun 2023 , 08:36 AM

Here are some stocks that may show significant price movement today.

1. HDFC Life: Housing Development Finance Corporation (HDFC), the promoter of the life insurance company, has acquired an additional 1.65 crore equity shares, representing a 0.77% stake, through open market transactions. The average price at which these shares were purchased was Rs 674.87 per share.
2. Adani Enterprises: SB Adani Family Trust, the promoter entity, has divested 1.8 crore equity shares, equivalent to a 1.57% stake in the company, through open market transactions. These shares were sold at an average price of Rs 2,300 per share.
3. BPCL: The oil marketing company’s board of directors has granted approval to raise capital of up to Rs 18,000 crore.
4. ICICI Bank: Both ICICI Bank and ICICI Securities have announced separate board approvals for the delisting of ICICI Securities. As a result, ICICI Securities will transition into a wholly-owned subsidiary of the private sector lender, ICICI Bank.
5. HDFC AMC: Sebi, to not grant any additional time for mutual fund houses with significant holdings in the merger-bound HDFC twins to realign their portfolios after the merger. This move by Sebi will likely require these mutual fund houses to adjust their holdings and align them with the revised structure resulting from the merger.
6. Adani Green Energy: Goldman Sachs Trust II – Goldman Sachs GQG Partners International Opportunities Fund has recently acquired an additional 1.19 crore equity shares, representing a 0.75% stake, in the renewable energy company through open market transactions. The average price per share for these transactions was Rs 920.05.
7. Aurobindo Pharma: The company has received four observations issued by the US FDA to Aurobindo Pharma’s Anakapalli Unit. The unit underwent inspection by the US FDA from May 15-19, 2023, as per CNBC TV18 sources.
8. Tata Communications: Tata Group company has reached an agreement to acquire Kaleyra Inc, a US-based company that operates subsidiaries in various countries including the United States of America, Italy, India, UAE, Germany, UK, Dominican Republic, Mexico, Africa, and Canada. The acquisition will enable the Tata Group to expand its presence and operations across these geographies through Kaleyra Inc’s established subsidiaries.
9. Zydus Lifesciences: The pharmaceutical company has obtained tentative approval from the US Food and Drug Administration (USFDA) for Palbociclib tablets. These tablets are available in strengths of 75 mg, 100 mg, and 125 mg. Palbociclib is prescribed for the treatment of a specific type of breast cancer.
10. Powergrid: The state-owned electric services company has obtained board approval for three investment proposals totaling Rs 389 crore. The approved investments include Rs 164.38 crore for establishing a dedicated telecom network for NTAMC, Rs 115.09 crore for the Western region expansion scheme – XXXIII – Part A, and Rs 109.47 crore for ICT augmentation at Navsari (new) related to the integration of an additional 7 GW of renewable energy power from Khavda RE park under Phase-III.